p.188 抽出テキスト

270. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet 2005; 365: 1577-1589. PMID: 15866312 271. MacSweeney ST, Ellis M, Worrell PC, et al. Smoking and growth rate of small abdominal aortic aneurysms. Lancet 1994; 344: 651- 652. PMID: 7915350 272. Wilmink TB, Quick CR, Day NE. The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg 1999; 30: 1099-1105. PMID: 10587395 273. Sode BF, Nordestgaard BG, Grønbæk M, et al. Tobacco smoking and aortic aneurysm: two population-based studies. Int J Cardiol 2013; 167: 2271-2277. PMID: 22726392 274. Elefteriades JA. Indications for aortic replacement. J Thorac Cardiovasc Surg 2010; 140 Suppl: S5-S9. PMID: 21092797 275. Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management: Part II: therapeutic management and follow-up. Circulation 2003; 108: 772-778. PMID: 12912795 276. Genoni M, Paul M, Jenni R, et al. Chronic beta-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection. Eur J Cardiothorac Surg 2001; 19: 606-610. PMID: 11343940 277. Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med 1994; 330: 1335-1341. PMID: 8152445 278. Kokje VB, Hamming JF, Lindeman JH. Editor’s Choice - Pharmaceutical Management of Small Abdominal Aortic Aneurysms: A Systematic Review of the Clinical Evidence. Eur J Vasc Endovasc Surg 2015; 50: 702-713. PMID: 26482507 279. Rughani G, Robertson L, Clarke M. Medical treatment for small abdominal aortic aneurysms. Cochrane Database Syst Rev 2012: CD009536. PMID: 22972146 280. 日本高血圧学会高血圧治療ガイドライン作成委員会編.高血圧治療ガイドライン 2019.ライフサイエンス出版 2019. 281. Peters R, Beckett N, Burch L, et al. The effect of treatment based on a diuretic (indapamide) ± ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET). Age Ageing 2010; 39: 609-616. PMID: 20573778 282. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041. PMID: 11589932 283. Heidenreich PA, McDonald KM, Hastie T, et al. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA 1999; 281: 1927-1936. PMID: 10349897 284. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357: 1385-1390. PMID: 11356434 285. Pfeffer MA, Braunwald E, Moyé LA, et al. The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669-677. PMID: 1386652 286. Køber L, Torp-Pedersen C, Carlsen JE, et al. Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670-1676. PMID: 7477219 287. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 2017; 136: e137-e161. PMID: 28455343 288. Ezekowitz JA, McAlister FA. Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J 2009; 30: 469-477. PMID: 19066207 289. Wachtell K, Lehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005; 45: 712-719. PMID: 15734615 290. Lindholt JS, Henneberg EW, Juul S, et al. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. Int Angiol 1999; 18: 52-57. PMID: 10392481 291. Nishimura K, Okamura T, Watanabe M, et al. Predicting Coronary

Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study. J Atheroscler Thromb 2016; 23: 1138-1139. PMID: 27582077 292. Imamura T, Doi Y, Arima H, et al. LDL cholesterol and the develop-

ment of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2009; 40: 382-388. PMID: 19095987 293. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/ AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 139: e1082-e1143. PMID: 30586774 294. 日本動脈硬化学会編.動脈硬化性疾患予防ガイドライン2017年版.日本動脈硬化学会 2017. 295. Grundy SM, Stone NJ. 2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol-Secondary Prevention. JAMA Cardiol 2019; 4: 589-591. PMID: 30994869 296. Takagi H, Yamamoto H, Iwata K, et al. ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies. Eur J Vasc Endovasc Surg 2012; 44: 287-292. PMID: 22824348 297. Jovin IS, Duggal M, Ebisu K, et al. Comparison of the effect on long-term outcomes in patients with thoracic aortic aneurysms of taking versus not taking a statin drug. Am J Cardiol 2012; 109: 1050-1054. PMID: 22221941 298. Twine CP, Williams IM. Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms. Br J Surg 2011; 98: 346-353. PMID: 21254006 299. Tazaki J, Morimoto T, Sakata R, et al. CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection. J Vasc Surg 2014; 60: 604-612. PMID: 24797553 300. Sato T, Arakawa M, Tashima Y, et al. Statins Reduce Thoracic Aortic Aneurysm Growth in Marfan Syndrome Mice via Inhibition of the Ras-Induced ERK (Extracellular Signal-Regulated Kinase) Signaling Pathway. J Am Heart Assoc 2018; 7: e008543. PMID: 30571378 301. McLoughlin D, McGuinness J, Byrne J, et al. Pravastatin reduces Marfan aortic dilation. Circulation 2011; 124 Suppl: S168-S173. PMID: 21911808 302. Dawson JA, Choke E, Loftus IM, et al. A randomised placebo-controlled double-blind trial to evaluate lipid-lowering pharmacotherapy on proteolysis and inflammation in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2011; 41: 28-35. PMID: 20880729 303. Raffort J, Lareyre F, Clément M, et al. Diabetes and aortic aneurysm: current state of the art. Cardiovasc Res 2018; 114: 1702-1713. PMID: 30052821 304. 日本糖尿病学会編.糖尿病治療ガイド2018-2019.文光堂 2018. 305. Brady AR, Thompson SG, Fowkes FG, et al. UK Small Aneurysm Trial Participants. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 2004; 110: 16- 21. PMID: 15210603 306. Lederle FA, Johnson GR, Wilson SE, et al. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. The aneurysm detection and management study screening program: validation cohort and final results. Arch Intern Med 2000; 160: 1425- 1430. PMID: 10826454 307. Kent KC, Zwolak RM, Egorova NN, et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 2010; 52: 539-548. PMID: 20630687 308. Forsdahl SH, Singh K, Solberg S, et al. Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994-2001. Circulation 2009; 119: 2202-2208. PMID: 19364978 309. Cornuz J, Sidoti Pinto C, Tevaearai H, et al. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur J Public Health 2004; 14: 343-349. PMID: 15542867 310. Kihara T, Yamagishi K, Iso H, et al. JACC Study Group. Passive smoking and mortality from aortic dissection or aneurysm. Atherosclerosis 2017; 263: 145-150. PMID: 28645070 311. Sweeting MJ, Thompson SG, Brown LC, et al. RESCAN collaborators. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012; 99: 655-665. PMID: 22389113 312. Hartmann-Boyce J, Aveyard P. Drugs for smoking cessation. BMJ 2016; 352: i571. PMID: 26907501 313. LeFevre ML, LeFevre ML. Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 161: 281-290. PMID: 24957320 314. Arinze N, Farber A, Levin SR, et al. The effect of the duration of